However, due to contribution of various other affecting factors of the miR-758 and HMGB3 gene, further studies are needed to explore the mechanism of miR-758 and HMGB3 gene and find more effective therapeutic regimens for NSCLC patients. Here, HMGB3 is linked to non-small cell lung carcinoma.